Skip to main content
. 2018 Mar 7;12(3):383–411. doi: 10.1111/irv.12522

Table 4.

Age distribution of confirmed influenza B cases (as a percentage of all influenza B)

Country Data source No. of influenza B cases Age distribution (years)
<5 5‐9 10‐19 20‐49 50‐64 ≥65
Australia Surveillance (Notified influenza cases)30 745 6.4 45 (5‐14) 46 (15‐49) 10 13
GP surveillance30 38 5 24 (5‐14) 63 (15‐49) 5 3
Surveillance (Complications alert network)30 50 10 8 (5‐14) 44 (15‐49) 8 30
Clinical samples23 55 0 10.9 0 34.5 34.5 20.0
Surveillance23 133 4.5 10.5 35.3 24.8 23.3 6.0
China Clinical patients135 83 14.5 34.9 (5‐14) 25.3 (15‐24) 22.9 (25‐59) 2.4 (≥ 60)
Clinical patients138 162 5.6 34.0 (5‐14) 14.2 (15‐24) 43.2 (25‐59) 3.1 (≥ 60)
Clinical patients133 96 29.2 68.8 (5‐14) 0 (15‐24) 2.1 (25‐59) 0 (≥ 60)
Clinical patients139 74 21.6 43.2 (5‐14) 18.9 (15‐24) 16.2 (25‐59) 0 (≥ 60)
Clinical patients127 404 ‐ (5‐14) 29.5 (15‐24) 65.5 (25‐59) 5.0 (≥ 60)
Clinical patients131 75 ‐ (5‐14) 50.7 (15‐24) 49.3 (25‐59) 0 (≥ 60)
Clinical patients41 6688 9.7 23.5 (6‐17) 61.4 (18‐64) 5.5
Indonesia Surveillance43 1487 15.0 33.8 (5‐12) 8.5 (13‐17) 38.0 (18‐49) 3.6 1.1
Laos Surveillance46 142 25.4 34.8 (5‐17) 39.8 (18‐64) 0
Surveillance47 92 13.0 41.3 (5‐17) 44.6 (18‐49) 1.1 0
Malaysia Clinical patients142 338 73.8 16.4 8.2 1.6
Myanmar Clinical patients51 125 43.2 32.6 13.8 2.2 (20‐59) 0 (≥ 60)
Clinical patients50 6 33 50 16.7 0 0 0
PNG Surveillance56 38 76 24 (>5)
Singapore Clinical samples82 92 45.3 10.5 8.2 36.0 (≥ 20)
South Korea Surveillance76 3217 48.7 18.4 5.0 7.7 6.5 13.1
Thailand Surveillance83 120 25.8 43.8 (5‐17) 12.5 (18‐49) 15.6 12.5
Surveillance84 150 26 34.7 (5‐17) 18.7 (18‐49) 20.7 (≥ 50)
Vietnam Surveillance58 585 22 41.5 (5‐14) 17.4 (25‐64) 1.7
Surveillance59 2163 68 (0‐15) 11.8 (16‐24) 18.0 (25‐64) 1.8

N, number; PNG, Papua New Guinea; GP, general practice; ILI, influenza‐like illness; LRTI, lower respiratory tract infection. Shading indicates values covering the combined shaded age groups.